Statement on Glucagen Hypokit supply 2 August 2023 Novo Nordisk has notified the Therapeutic Goods Administration that the Glucagen Hypokit is currently in a shortage that will last until 30 September 2023. The Glucagen Hypokit is used to treat severe hypoglycaemia where a person is unconscious or unable to take oral hypo treatments. If a person has a severe hypo and you don’t have a Hypokit you need to call 000 immediately. Diabetes Australia is working with the diabetes sector and the TGA to ensure people at highest risk are prioritized access to available supply. The TGA have also activated Section 19A provisions and is arranging imports of Hypokits from other countries. If you have concerns please talk to someone from your diabetes healthcare team.
Blog 4 December 2023 Are you up to date with your COVID-19 vaccination? As we head into the festive season it's a good time to make sure you are up-to-date with your COVID-19 vaccination. Continue Reading
Media releases 22 November 2023 Regional and remote Australians urged to get late flu vaccine People living with diabetes in rural and remote areas are being urged to get their flu shot now after low rates of flu vaccinations have put communities at risk across Australia this year. Continue Reading
Media releases 15 November 2023 New diabetes research announced – DKA Professor Tony Russell, a leading endocrinologist and president of the Australian Diabetes Society, is a recipient of this year’s Diabetes Australia Research Program’s (DARP) Millenium Award for a multicentre trial into the treatment of diabetic ketoacidosis (DKA), a little-known but potentially fatal complication of diabetes. Continue Reading
